Arca
Skip to content
Tools
Tools

Insulin resistance

Drug research and approvals for insulin resistance: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 387 studies of insulin resistance are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and FDA has 0 approved and 1 open orphan designations naming it.

  • Recruiting worldwide: 387
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 387 recruiting on ClinicalTrials.gov ↗

Drug pipeline

Each drug at the furthest stage it has reached for this condition, from ChEMBL's drug indications

Phase 3 10

Phase 2 7

Phase 1 or earlier 12 of 19

How its trials ended

1,644 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 331 whose ending is known, 45% met their primary endpoint, 11% missed it and 44% stopped early.

  • Completed, result not reported90755%
  • Ongoing22314%
  • Status unknown18311%
  • Met its primary endpoint1499%
  • Stopped: other or unclear905%
  • Missed its primary endpoint362%
  • Stopped: enrollment or feasibility312%
  • Stopped: funding111%
  • Stopped: lack of efficacy7<1%
  • Stopped: sponsor or business decision5<1%
  • Stopped: safety2<1%

FDA orphan designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Dec 9, 2003rhIGF-I/rhIGFBP-3Treatment of extreme insulin resistance syndromes (type A, Rabson-Mendenhall syndrome, Leprechaunism, type B syndrome)Insmed, Inc.Designated

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.